1. Home
  2. NRDY vs MGNX Comparison

NRDY vs MGNX Comparison

Compare NRDY & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

HOLD

Current Price

$0.80

Market Cap

102.7M

Sector

Technology

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$2.93

Market Cap

115.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRDY
MGNX
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.7M
115.8M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
NRDY
MGNX
Price
$0.80
$2.93
Analyst Decision
Hold
Hold
Analyst Count
1
5
Target Price
$1.00
$3.40
AVG Volume (30 Days)
829.4K
1.5M
Earning Date
05-07-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
13.16
N/A
EPS
N/A
N/A
Revenue
N/A
$149,500,000.00
Revenue This Year
$6.22
N/A
Revenue Next Year
$8.64
$16.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.99
52 Week High
$1.90
$3.50

Technical Indicators

Market Signals
Indicator
NRDY
MGNX
Relative Strength Index (RSI) 35.57 58.32
Support Level $0.78 $1.46
Resistance Level $0.99 $3.50
Average True Range (ATR) 0.06 0.28
MACD -0.00 -0.02
Stochastic Oscillator 14.06 27.22

Price Performance

Historical Comparison
NRDY
MGNX

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: